SHL TELEMEDICINE LTD. Press release
SGM Postponed to December 10, 2018 per Major Shareholders' Request
Tel Aviv / Zurich, 15 October 2018 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) ("SHL"), a leading provider and developer of advanced personal telemedicine solutions, announced today that per the request of each of its three major shareholders: the Alroy Group (holding 23.05% of the shares), Ms. Mengke Cai (holding 29.85%) and Ms. Kun Shen (holding 25.02%), SHL's board of directors has resolved to postpone the Special General Meeting Scheduled for October 18, 2018 to December 10, 2018.
The record date was set for December 3, 2018. An updated notice to shareholders and ballot shall be published no later than November 6, 2018.
For further information please contact:
Martin Meier-Pfister, IRF Communications, Phone: +41 43 244 81 40, shl@irfcom.ch
About SHL Telemedicine
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). For more information, please visit the web site at www.shl-telemedicine.com.
| Provider | Channel | Contact | ||
|---|---|---|---|---|
|
EQS Group Ltd., Switzerland switzerland.eqs.com |
newsbox.ch www.newsbox.ch |
Provider/Channel related enquiries cs.switzerland@eqs.com +41 41 763 00 50 |
